M2D2 Resident Company Allergy Amulet’s CEO Named One of 2019’s 100 Coolest People in Food and Drink

Allergy Amulet CEO Abigail Barnes

M2D2 resident companies continue to make news in 2019. In June, Business Insider ranked the 100 most influential and interesting people in the food and drink industry. This list includes other notable names, like Sarah Kauss, founder of S’well, Meghan Markle, and Andy Levitt, founder of Purple Carrot. Abigail Barnes, CEO of Allergy Amulet, was listed at number 22! She was recognized for developing the Allergy Amulet, and the positive impact this food sensor will have for people managing food allergies.

Continue reading

M2D2 Resident Company LaunchPad Medical Approved for FDA Clinical Studies

Last week, another M2D2 resident company achieved a significant milestone. LaunchPad Medical received approval from the FDA to start a clinical study examing the safety and success of their bone adhesive biomaterial, Tetranite®.

About LaunchPad Medical

LaunchPad Medical, Inc. is primarily involved with the development of an injectable, self-setting osteoconductive bone adhesive material (Tetranite®). While the company’s focus is to use this technology within the dental market, they have also been working on developing adhesive applications for a larger scope of the orthopedics market. 

Continue reading

RQMIS Inc. Announces UMass M2D2 Sponsorship

M2D2, its resident companies, and the medical device and biotech innovation community in Lowell and Worcester are pleased to welcome RQMIS Inc. as an M2D2 Platinum Corporate Sponsor.

Based in Amesbury, Massachusetts and with sister companies in the UK and Spain, RQMIS provides therapeutically focused, comprehensive regulatory consultation to the global medical device, pharmaceutical, combination product, dietary supplement and human tissue industry. As part of its M2D2 Sponsorship, RQMIS will participate in the $200K Challenge, including the call for applications, applicant screening, and judging the final competition showcase. Regularly throughout the year, RQMIS will offer educational sessions and host office hours to provide mentoring and share insights with M2D2 resident start-up companies.

Continue reading

M2D2 Resident Company Glyscend Receives New Funding from Breakout Labs

This year has brought many exciting achievements for M2D2 resident companies—and here’s one more. Glyscend, a polymer therapeutics company focused on revolutionizing Type 2 diabetes treatment, has been named one of two startup labs selected to receive funding from Breakout Labs. Glyscend operates facilities at both M2D2 in Lowell and at the Johns Hopkins Fast Forward facility in Baltimore.

Continue reading

UMass Lowell Receives Funding from MLSC to Advance New Continuous Manufacturing Process

This spring UMass Lowell Department of Chemical Engineering, and the UML’s Massachusetts Biomanufacturing Center received funding through the Massachusetts Life Science Center “Building Breakthroughs” program. The funding will support continuous bioprocessing manufacturing as an alternative to batch manufacturing. This new process is being explored in the manufacturing of small molecule drugs by the pharmaceutical industry. event where organizations received funding The research grant is part of a consortium that includes the M2D2 resident company (and 2018 $200K Challenge finalist) Versatope Therapeutics, who have developed an exosome-like vesicle technology currently used for vaccines. With this funding, these organizations are creating a truly transformative “continuous manufacturing” process for biopharmaceutical manufacturing. Continue reading

M2D2 resident company LivOnyx named a 2019 winner in MLSC MassNextGen Initiative

Lt. Gov. Karyn Polito (far left), LivOnyx President/Co-Founder Carmela Mascio (second from left), and MLSC President Travis McCready (third from right) at the MassNextGen winners announcement event on June 19.

We’re thrilled to spread the word that one of our innovative resident companies, LivOnyx, has been named one of five 2019 winners in the Massachusetts Life Sciences Center (MSLC) Massachusetts Next Generation Initiative. LivOnyx will receive $87,500 in funding, as well as access for a year to a network of executive coaches.  

Continue reading

New EZ BAA Portal Makes BARDA DRIVe Submissions Easier, Speeds Grant Awards.

The new BARDA DRIVe online portal speeds the awarding of grants to health security innovators.

The BARDA DRIVe team is pleased to announce that the new, easy-to-use EZ BAA online Portal is now live as of April 23, 2019. This Portal will replace the existing PDF-based process, helping to improve the user experience, data integrity, and data security. The system will also streamline internal processes, helping DRIVe’s program teams continue to make awards in as few as 30 days.

Continue reading

A Passage FROM India: Chennai-based startups compete in 2019 $200K Challenge

Team India at the 2019 M2D2 $200K Challenge Pitch-Off

With support from the Deshpande Foundation, three finalist startups from an incubator in Chennai, India were able to pitch their life sciences innovations in Lowell on March 27.  Not only did they compete, but they were also able to immerse themselves first-hand in the burgeoning biotech ecosystem that’s making Boston and environs the talk of the innovation economy.

Continue reading